Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ATAI LIFE SCIENCES N.V.
10/11ATAI LIFE SCIENCES N : Chymia Form Precision Psychiatry Company to Develop Targeted Depres..
MT
10/11ATAI LIFE SCIENCES N : announces the launch of PsyProtix, to develop a precision psychiatr..
AQ
10/11Atai Life Sciences Announces the Launch of Psyprotix, to Develop A Precision Psychiatry..
CI
09/21ATAI LIFE SCIENCES N : Unit Starts Dosing in Phase 1/2a Trial of Ibogaine in Opioid Use Di..
MT
09/21ATAI LIFE SCIENCES N : DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogain..
AQ
09/15ATAI LIFE SCIENCES N : Increases Loan in Principal by US$6m to Support IntelGenx's Graduat..
AQ
09/14ATAI LIFE SCIENCES N : ' Perception Neuroscience Initiates Phase 2a Study of PCN-101 to Tr..
MT
09/14ATAI LIFE SCIENCES N : Perception Neuroscience initiates Phase 2a study of PCN-101 (R-keta..
AQ
09/09atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeuti..
GL
09/09Atai Life Sciences and Introspect Digital Therapeutics to Test Novel Digital Therapeuti..
CI
09/03ATAI LIFE SCIENCES N : to Participate in Upcoming September Investor Conferences
AQ
09/01ATAI LIFE SCIENCES N : Jefferies Starts Atai Life Sciences at Buy with $27 Price Target
MT
08/16Asian ADRs Tumble Lower in Monday Trading
MT
08/16ATAI LIFE SCIENCES N : ' Q2 Loss Widens as Total Operating Expenses Rise
MT
08/16ATAI LIFE SCIENCES N : Reports Second Quarter 2021 Financial Results and Business Update (..
PU
More most relevant news
All news about ATAI LIFE SCIENCES N.V.
10/11ATAI LIFE SCIENCES N : Chymia Form Precision Psychiatry Company to Develop Targeted Depres..
MT
10/11ATAI LIFE SCIENCES N : announces the launch of PsyProtix, to develop a precision psychiatr..
AQ
10/11Atai Life Sciences Announces the Launch of Psyprotix, to Develop A Precision Psychiatry..
CI
10/05Asian ADRs Move Higher in Tuesday Trading
MT
10/01Asian ADRs Sharply Lower Friday as China Education Stocks Slide
MT
09/21ATAI LIFE SCIENCES N : Unit Starts Dosing in Phase 1/2a Trial of Ibogaine in Opioid Use Di..
MT
09/21ATAI LIFE SCIENCES N : DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogain..
AQ
09/15ATAI LIFE SCIENCES N : Increases Loan in Principal by US$6m to Support IntelGenx's Graduat..
AQ
09/14ATAI LIFE SCIENCES N : ' Perception Neuroscience Initiates Phase 2a Study of PCN-101 to Tr..
MT
09/14ATAI LIFE SCIENCES N : Perception Neuroscience initiates Phase 2a study of PCN-101 (R-keta..
AQ
More news
News in other languages on ATAI LIFE SCIENCES N.V.
10/11Atai Life Sciences et Chymia créent une société de psychiatrie de précision pour dévelo..
10/05Les ADR asiatiques en hausse mardi
10/01Les ADR asiatiques ont fortement baissé vendredi en raison de la chute des valeurs éduc..
09/21Atai Unit commence le dosage dans le cadre de l'essai de phase 1/2a sur l'ibogaïne dans..
09/14Perception Neuroscience, filiale d'Atai Life Sciences, lance une étude de phase 2a sur ..
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
09/01ATAI LIFE SCIENCES N : Jefferies Starts Atai Life Sciences at Buy with $27 Price Target
MT
07/13ATAI LIFE SCIENCES N : Berenberg Bank Initiates Coverage on Atai Life Sciences With Buy Ra..
MT
07/13ATAI LIFE SCIENCES N : Cantor Fitzgerald Starts Atai Life Sciences at Overweight With $45 ..
MT
07/13ATAI LIFE SCIENCES N : Credit Suisse Starts Atai Life Sciences at Outperform with $25 PT, ..
MT
07/13ATAI LIFE SCIENCES N : RBC Capital Initiates Atai Life Sciences at Sector Perform, Specula..
MT
More recommendations
Press releases
10/11ATAI LIFE SCIENCES N : announces the launch of PsyProtix, to develop a precision psychiatr..
AQ
09/21ATAI LIFE SCIENCES N : DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogain..
AQ
09/15ATAI LIFE SCIENCES N : Increases Loan in Principal by US$6m to Support IntelGenx's Graduat..
AQ
09/14ATAI LIFE SCIENCES N : Perception Neuroscience initiates Phase 2a study of PCN-101 (R-keta..
AQ
09/09atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeuti..
GL
More press releases
Upcoming sector events